Sanofi SA (NASDAQ:SNY)

49.99
Delayed Data
As of 4:01pm ET
 -2.66 / -5.05%
Today’s Change
46.93
Today|||52-Week Range
58.10
-0.22%
Year-to-Date
Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted
8:56am / Zacks.com - Paid Partner Content
Sanofi (SNY) Wins Nod for Nexviadyme & Xenpozyme in Europe
Jun 28 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: FDA Panel Backs Updated COVID Jabs, EU Nod for SNY, MRK Drugs
8:46am / Zacks.com - Paid Partner Content
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Jun 25 / MotleyFool.com - Paid Partner Content
Investors Need Not Be Alarmed by Drug Patent Expirations
Jun 28 / GuruFocus News - Paid Partner Content
Why Sanofi May Be a Frontrunner in Endemic COVID-19
Jun 25 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close52.65
Today’s open50.13
Day’s range49.82 - 50.61
Volume305,063
Average volume (3 months)2,244,697
Market cap$134.0B
Data as of 4:01pm ET, 06/30/2022

Growth & Valuation

Earnings growth (last year)-47.56%
Earnings growth (this year)-96.15%
Earnings growth (next 5 years)+8.75%
Revenue growth (last year)+8.63%
P/E ratio19.3
Price/Sales2.82
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.24-0.55%
BMYBristol-Myers Squibb-0.74-0.95%
ZTSZoetis Inc-1.83-1.05%
----
Data as of 4:02pm ET, 06/30/2022

Financials

Last reporting date--
EPS forecast (this quarter)$0.70
Annual revenue (last year)$44.6B
Annual profit (last year)$7.4B
Net profit margin16.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Paris, Ile-de-france

Forecasts